Performance of Current Thromboembolism Risk Assessment Tools in Patients With Gastric Cancer and Validity After First Treatment.

about

Performance of Current Thromboembolism Risk Assessment Tools in Patients With Gastric Cancer and Validity After First Treatment.

Item

http://www.wikidata.org/entity/Q48105964

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Performance of Current Thrombo ...... alidity After First Treatment.

@en

Performance of Current Thrombo ...... alidity After First Treatment.

@nl

type

Item

label

Performance of Current Thrombo ...... alidity After First Treatment.

@en

Performance of Current Thrombo ...... alidity After First Treatment.

@nl

prefLabel

Performance of Current Thrombo ...... alidity After First Treatment.

@en

Performance of Current Thrombo ...... alidity After First Treatment.

@nl

P1476

Performance of Current Thrombo ...... Validity After First Treatment

@en

P2093

A J Tafur

http://www.w3.org/2001/XMLSchema#string

C R Simons

http://www.w3.org/2001/XMLSchema#string

D M Oramas

http://www.w3.org/2001/XMLSchema#string

Harry E Fuentes

http://www.w3.org/2001/XMLSchema#string

L H Paz

http://www.w3.org/2001/XMLSchema#string

Y Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL).

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006

The prothrombotic state in cancer: pathogenic mechanisms.

Incidence of venous thromboembolism in patients hospitalized with cancer.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.

P304

790-796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1076029617726599

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28884610

http://www.w3.org/2001/XMLSchema#string

P921

thromboembolism

P932

6714876

http://www.w3.org/2001/XMLSchema#string